Filing Details

Accession Number:
0001209191-15-034737
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2015-04-16 21:25:42
Reporting Period:
2014-12-19
Filing Date:
2015-04-16
Accepted Time:
2015-04-16 21:25:42
Original Submission Date:
2014-12-22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1513818 Versartis Inc. VSAR Pharmaceutical Preparations (2834) 244106690
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1601948 L Jeffrey Cleland C/O Versartis, Inc.
4200 Bohannon Drive, Suite 250
Menlo Park CA 94025
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-11-14 1,900 $0.00 141,388 No 5 G Direct
Common Stock Disposition 2014-12-19 20 $20.00 141,368 No 4 S Direct
Common Stock Disposition 2014-12-22 2,110 $20.54 139,258 No 4 S Direct
Common Stock Disposition 2014-12-22 5,870 $21.36 133,388 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Includes 892 shares purchased on 11/14/14 pursuant to the issuer's employee stock purchase plan.
  2. Shares sold pursuant to a 10b5-1 trading plan.
  3. The shares were sold at prices ranging from $20.04 to $21.03. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. The shares were sold at prices ranging from $21.06 to $21.87. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.